Tabuteau Herriot
Axsome Therapeutics, Inc. · Chief Executive Officer
Tabuteau Herriot is listed in public filings as director, 10 percent owner, officer: Chief Executive Officer. This Tabuteau Herriot insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Axsome Therapeutics, Inc. (AXSM). Investors use Tabuteau Herriot's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $23M99.3k shares | Grant / ExerciseJun 9, 2026 | $12.0M49.7k shares | $241.01 | $234.52 | |
| $1.7M7.2k shares | SellJun 9, 2026 | $12.0M49.7k shares | $241.01 | $234.52 | |
| $13M56.9k shares | Grant / ExerciseJun 9, 2026 | $245.9K49.7k shares | $4.95 | $234.52 |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| Historical actions before the latest disclosure date will appear here after more snapshots are available. | |||||